USANA HEALTH SCIENCES INC
For the period ended Mar 30, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 30, 2024 · Filed May 7, 2024
USNA$13.10-5.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income
| Quarter Ended | ||
|---|---|---|
| March 30,2024 | April 1,2023 | |
| Net sales | $227,800 | $248,360 |
| Cost of sales | 43,069 | 48,519 |
| Gross profit | 184,731 | 199,841 |
| Operating expenses: | ||
| Associate incentives | 95,758 | 106,070 |
| Selling, general and administrative | 64,300 | 66,926 |
| Total operating expenses | 160,058 | 172,996 |
| Earnings from operations | 24,673 | 26,845 |
| Other income (expense): | ||
| Interest income | 2,676 | 1,775 |
| Interest expense | (52) | (31) |
| Other, net | (186) | (88) |
| Other income (expense), net | 2,438 | 1,656 |
| Earnings before income taxes | 27,111 | 28,501 |
| Income taxes | 10,574 | 10,118 |
| Net earnings | $16,537 | $18,383 |
| Earnings per common share | ||
| Basic | $0.86 | $0.95 |
| Diluted | $0.86 | $0.95 |
| Weighted average common shares outstanding | ||
| Basic | 19,174 | 19,283 |
| Diluted | 19,302 | 19,328 |
| Comprehensive income: | ||
| Net earnings | $16,537 | $18,383 |
| Other comprehensive income (loss), net of tax: | ||
| Foreign currency translation adjustment | (5,102) | 1,654 |
| Tax benefit (expense) related to foreign currency translation adjustment | 204 | 98 |
| Other comprehensive income (loss), net of tax | (4,898) | 1,752 |
| Comprehensive income | $11,639 | $20,135 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.